Related Experiment Video

Updated: May 25, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

S E Jalava1, A Urbanucci, L Latonen

  • 1Institute of Biomedical Technology, Tampere University, Tampere, Finland.

Oncogene
|January 24, 2012
PubMed

Insights

Androgen-regulated microRNAs (miRNAs) like miR-32 are linked to aggressive castration-resistant prostate cancer (CRPC). Overexpression of miR-32 reduces BTG2, a potential marker for advanced disease and a drug target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The androgen receptor (AR) signaling pathway is crucial in castration-resistant prostate cancer (CRPC) development.
  • MicroRNAs (miRNAs) are increasingly recognized as key regulators in cancer progression.

Purpose of the Study:

  • To identify androgen-regulated miRNAs involved in CRPC.
  • To investigate the functional roles of specific miRNAs, miR-32 and miR-148a, in prostate cancer.
  • To elucidate the molecular mechanisms underlying the action of these miRNAs and their target genes.

Main Methods:

  • Microarray analysis to identify differentially expressed miRNAs in CRPC vs. benign prostate hyperplasia (BPH).
  • Cell transfection experiments to assess the functional impact of miR-32 and miR-148a on cell growth, proliferation, and apoptosis.
  • Chromatin immunoprecipitation (ChIP) to confirm AR binding sites near miRNA genes.
  • mRNA microarray, Western blot, and 3'UTR-luciferase assays to identify and validate miRNA targets (BTG2 and PIK3IP1).
  • Immunohistochemistry to evaluate protein expression in patient samples.

Main Results:

  • Seven miRNAs, including miR-32 and miR-148a, were differentially expressed in CRPC.
  • Overexpression of miR-32 reduced apoptosis, while miR-148a enhanced proliferation in LNCaP cells.
  • Androgen regulation of miR-32 and miR-148a was confirmed.
  • BTG2 and PIK3IP1 were identified as direct targets of miR-32 and miR-148a, respectively, with reduced protein expression.
  • BTG2 protein was significantly reduced in CRPCs, and its absence correlated with shorter progression-free survival.

Conclusions:

  • Androgen-regulated miR-32 is overexpressed in CRPC and contributes to disease progression by downregulating BTG2.
  • miR-32 represents a potential biomarker for aggressive prostate cancer.
  • miR-32 is a putative therapeutic target for prostate cancer treatment.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...